Please login to the form below
idebenone
This page shows the latest idebenone news and features for those working in and with pharma, biotech and healthcare.
Mallinckrodt doses first patient in muscular dystrophy trial
Other therapeutic approaches under test for DMD include gene-editing with CRISPR/Cas9, myostatin inhibitors from Pfizer, Bristol-Myers Squibb and Biogen/AliveGen, and Santhera’s antioxidant idebenone, which like
Latest news
-
Summit plunges after Duchenne disappointment
These include the use of CRISPR/Cas9, myostatin Inhibitior candidates from Pfizer and BMS, and Santhera which is developing Idebenone (Raxone).
-
CHMP hands Santhera second ‘no’ in Duchenne muscular dystrophy
European regulatory advisers have refused to shift their negative position on Santhera’s Duchenne muscular dystrophy (DMD) drug Raxone (idebenone).
-
Santhera facing long delay for muscular dystrophy drug in US
The Swiss biopharma company has failed to convince the FDA to accept an accelerated marketing application for Raxone (idebenone) via the truncated subpart H approval pathway, used to hasten the approval
-
BioMarin gives up on muscular dystrophy drug
There has been some good news for European DMD patients this week however after Santhera announced it had filed for approval of Raxone (idebenone) for the treatment of DMD.
-
Ten new medicines recommended in Europe
And finally the CHMP has recommended Santhera's Raxone (idebenone) for the treatment of visual impairment in patients with Leber's hereditary optic neuropathy. .
More from news
Approximately 3 fully matching, plus 8 partially matching documents found.
Featured jobs
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Manager / Account Director
-
Competative
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Account Director
-
£48, 000 - £60, 000
-
Senior Medical Writer
-
Great salary and benefits
-
New Business Director - PR
-
Competitive Salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Associate Director
-
£75, 000-90, 000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
Excellent benefits
Subscribe to our email news alerts
- Behaviour change: what is the buzz all about?
- Worldwide Clear Aligner Market to grow at a CAGR of 16.15% By 2023
- Worldwide Prenatal and New-born Genetic Testing Market Set to Register 11.9% CAGR During 2018-2024
- Medical Biomimetics Market soaring at 5.5% CAGR to Hit USD 34.4 Billion By 2024
- Medical Marijuana Market to Soar at 36% CAGR to 2024
- Worldwide Medical Ultrasound Imaging Equipment Market to Witness Robust Expansion Throughout the Forecast Period 2018 – 2023
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
